Search Results - "Angonese, C"

Complications of radiofrequency thermal ablation in hepatocellular carcinoma: what about “explosive” spread? by Angonese, C, Baldan, A, Cillo, U, D’Alessandro, A, De Antoni, M, De Giorgio, M, Masotto, A, Marino, D, Massani, M, Mazzucco, M, Miola, E, Neri, D, Paccagnella, D, Pivetta, G, Tommasi, L, Tremolada, F, Tufano, A, Zanus, G, Farinati, F

“…Suggested risk factors have been high α fetoprotein levels, location near major portal branches, and poor tumour differentiation. 4, 5 Also, increased liver…”
Get full text

Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma by BALDAN, A., MARINO, D., DE GIORGIO, M., ANGONESE, C., CILLO, U., D'ALESSANDRO, A., MASOTTO, A., MASSANI, M., MAZZUCCO, M., MIOLA, E., NERI, D., PACCAGNELLA, D., PIVETTA, G., STELLATO, A., TOMMASI, L., TREMOLADA, F., TUFANO, A., ZANUS, G., FARINATI, F.

“…Summary Background Radiofrequency thermal ablation is the first therapeutic option in percutaneous treatment of hepatocellular carcinoma but data on its…”
Get full text

Prognostic and diagnostic role of VEGF-A and HIF-1α in hepatocellular carcinoma treated with chemoembolization by Peserico, G., Pinto, E., Sartori, A., Imondi, A., Pelizzaro, F., Penzo, B., Angonese, C., Cillo, U., A.Vitale, Trevisani, F., Farinati, F.

Get full text

Histological study of alcoholic, nonalcoholic, and obstructive chronic pancreatitis by DE ANGELIS, C, VALENTE, G, SPACCAPIETRA, M, ANGONESE, C, DEL FAVERO, G, NACCARATO, R, ANDRIULLI, A

“…Pancreatic tissue obtained from 26 patients with alcoholic chronic pancreatitis (ACP), nine patients with nonalcoholic idiopathic chronic pancreatitis (NAICP),…”
Get full text

Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma? by Leandro, G, Zizzari, S, Fabris, C, Basso, D, Elba, S, Del Favero, G, Meggiato, T, Angonese, C, Di Mario, F, Manghisi, O G

“…This study was undertaken in order to compare the ability of 4 tumour markers to discriminate between liver cirrhosis patients with or without hepatocellular…”
Get more information

Combined determination of serum CA 19-9 and tissue polypeptide antigen: why no improvement in pancreatic cancer diagnosis? by Basso, D, Fabris, C, Del Favero, G, Panucci, A, Plebani, M, Angonese, C, Leandro, G, Dodi, G, Burlina, A, Naccarato, R

“…CA 19-9 and tissue polypeptide antigen (TPA) were determined in the sera of 28 control subjects, 29 patients with pancreatic cancer, 26 with chronic…”
Get more information

Renal tubular dysfunction in pancreatic cancer and chronic pancreatitis by Fabris, C, Basso, D, Del Favero, G, Piccoli, A, Angonese, C, Di Mario, F, Plebani, M, Bonvicini, P, Burlina, A, Naccarato, R

“…Urinary excretion of alpha-glucosidase (AGL), gamma-glutamyltransferase (GGT) and ribonuclease (RNase), and serum amylase and immunoreactive trypsin (IRT) were…”
Get more information

Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age by Basso, D, Fabris, C, Del Favero, G, Angonese, C, Meggiato, T, Infantino, A, Plebani, M, Piccoli, A, Leandro, G, Burlina, A

“…In order to verify the role of CEA in the differential diagnosis of pancreatic cancer and to evaluate some influencing factors like age, tumor spread and liver…”
Get more information

Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases by Plebani, M, Basso, D, Fabris, C, Meggiato, T, Del Favero, G, Panozzo, M P, Fogar, P, Faggian, D, Angonese, C, Burlina, A

“…Serum TATI (tumor-associated trypsin inhibitor) was measured in 41 control subjects, 30 patients with pancreatic cancer, 53 with chronic pancreatitis, and 47…”
Get full text

Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis by Marafin, C, Rinaldi, M, Angonese, C, De Franchis, G, Plebani, M, Naccarato, R, Farinati, F

“…The immune response in liver cirrhosis and hepatocellular carcinoma is receiving renewed attention in consideration of the possible treatment with biological…”
Get more information

Pancreolauryl test in chronic pancreatitis by Panucci, A, Angonese, C, Del Favero, G, Fabris, C, Marchioro, L, Basso, D, Di Mario, F, Naccarato, R

“…The pancreolauryl test was performed in 30 subjects with chronic pancreatitis, in order to evaluate its behavior in relation to the duration of the clinical…”
Get full text

Cytology in the diagnosis of pancreatic cancer by Del Favero, G, Fabris, C, Angonese, C, Basso, D, Rebuffi, A, Costantin, G, Matarazzo, R, Di Mario, F, Naccarato, R

“…The study of cytology in duodenal and/or pure pancreatic juice has been proposed in the differential diagnosis of pancreatic cancer. In our experience the…”
Get more information

Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis by Basso, D, Fabris, C, Panucci, A, Del Favero, G, Angonese, C, Plebani, M, Petrin, P, Burlina, A, Naccarato, R

“…The clinical usefulness of tissue polypeptide antigen, galactosyltransferase II and pancreatic oncofetal antigen was evaluated in detecting pancreatic cancer…”
Get more information

Limits of CEA and ferritin in the diagnosis of pancreatic cancer by Plebani, M, Fabris, C, Basso, D, Del Favero, G, Angonese, C, Leandro, G, Di Mario, F, Burlina, A, Naccarato, R

“…In this paper the clinical usefulness of CEA and ferritin in the diagnosis of pancreatic cancer was pointed out. CEA was found to be increased in 51% of…”
Get more information

Ribonucleases and deoxyribonucleases in pancreatic cancer: clinical value and pathophysiological interrelationships by Del Favero, G, Basso, D, Fabris, C, Angonese, C, Meani, A, Vianello, D, Pedrazzoli, S, Dodi, G, Naccarato, R

“…In this study we evaluated some pathophysiological aspects of pancreatic and liver ribonucleases and alkaline deoxyribonuclease and their clinical usefulness…”
Get more information

Renal involvement in chronic pancreatic disease: effects on trypsin and amylase plasma-urine transfer by Fabris, C, Basso, D, Del Favero, G, Benini, L, Angonese, C, Piccoli, A, Plebani, M, Burlina, A, Naccarato, R

“…This study was undertaken in order to ascertain the behaviour of amylase and trypsin fractional clearances in chronic pancreatic disease and to speculate on…”
Get more information

How does liver dysfunction influence serum CA 19-9 in pancreatic cancer? by Basso, D, Fabris, C, Del Favero, G, Piccoli, A, Angonese, C, Pasquali, C, Castoro, C, Plebani, M, Leandro, G, Burlina, A

“…Serum CA 19-9 was determined in 83 control subjects, 99 patients with pancreatic cancer, 104 with chronic pancreatitis and 137 with extra-pancreatic diseases…”
Get more information

C reactive protein in pancreatic cancer and chronic pancreatitis by Basso, D, Fabris, C, Meani, A, Del Favero, G, Vianello, D, Angonese, C, Meggiato, T, Bellinvia, S, Fogar, P, Petrin, P

“…Serum C reactive protein was determined in 30 control subjects, 32 patients with pancreatic cancer, 28 with chronic pancreatitis and 23 with extra-pancreatic…”
Get more information

Urinary elastase 1 in chronic pancreatic disease by Fabris, C, Basso, D, Benini, L, Meggiato, T, Del Favero, G, Cavallini, G, Panozzo, M P, Fogar, P, Angonese, C, Vantini, I

“…Serum and urine elastase 1, its renal output and clearance and urinary gamma-glutamyltransferase and ribonuclease excretions were measured in 16 patients with…”
Get more information

Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach by Fabris, C, Del Favero, G, Basso, D, Piccoli, A, Meggiato, T, Angonese, C, Plebani, M, Leandro, G, Burlina, A, Naccarato, R

“…In order to assess the value of serum markers and simple clinical data in the differential diagnosis of pancreatic cancer, we studied 32 control subjects and…”
Get more information